Two European patents approved for tissue diagnostics
"Another milestone is passed as Lumito's third patent family now is granted in Europe as the first region. The patent (WO2018224688A1 ), ”A method of anaIysing a sampIe for at Ieast one anaIyte”, specifically contains the area of application that Lumito's first product launch is targetingand protects the Company's in vitro diagnostics based on upconversion nanoparticles (UCNP). We hope that the European approval will be followed by approval in other regions," says Urban Widén, Lumito's acting CEO. Urban Widén is also